Danielle Helminski
University of Michigan
9 Papers
Danielle Helminski is an academic researcher from University of Michigan. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 1, co-authored 2 publications.
Chat about Author
Papers
Dashboards in Health Care Settings: Protocol for a Scoping Review
Danielle Helminski,Jacob E. Kurlander,Anjana Deep Renji,Jeremy B. Sussman,Paul N. Pfeiffer,Marisa L. Conte,Oliver J. Gadabu,Alex N. Kokaly,Rebecca H. Goldberg,Allison Amadea Ranusch,Laura J. Damschroder,Zachary Landis-Lewis +11 more
TL;DR: A survey of the vast published literature of “dashboards” to describe where, why, and for whom they are used in health care settings, as well as how they are developed, implemented, and evaluated and how the design, end user, and context influence their uptake and effectiveness.
Opioid Policy and Chronic Pain Treatment Access Experiences: A Multi-Stakeholder Qualitative Analysis and Conceptual Model.
Stephanie Slat,Avani Yaganti,Jennifer Thomas,Danielle Helminski,Michele Heisler,Amy S.B. Bohnert,Pooja Lagisetty +6 more
TL;DR: In this article, the authors investigated barriers to primary care access and multimodal treatment for chronic pain from the perspective of multiple stakeholders, including patients, primary care clinicians, and office staff.
Association of Anti-Secretory Drugs with Upper Gastrointestinal Bleeding in Patients Using Oral Anticoagulants: A Systematic Review and Meta-Analysis.
Jacob E. Kurlander,G Barnes,Aaron Fisher,Juan J. Gonzalez,Danielle Helminski,Sameer D. Saini,Neil Sengupta,Yuxiang Yang,James M. Scheiman,Loren Laine +9 more
TL;DR: The role of antisecretory drugs for the prevention of upper gastrointestinal bleeding in patients using anticoagulants is investigated in a systematic review and meta-analysis as mentioned in this paper , where six observational studies and one randomized trial were included.
16
Trials of Dual Antiplatelet Therapy After Percutaneous Coronary Intervention Lack Strategies to Ensure Appropriate Gastroprotection.
Jacob E. Kurlander,Geoffrey D. Barnes,Devraj Sukul,Danielle Helminski,Alex N. Kokaly,Kevin D. Platt,Hitinder S. Gurm,Sameer D. Saini +7 more
TL;DR: It is evaluated the extent to which contemporary trials of DAPT included steps to ensure appropriate use of proton pump inhibitor gastroprotection and reported rates of PPI use and whether this represents an important opportunity to improve patient safety.
4
Prescribing of proton pump inhibitors for prevention of upper gastrointestinal bleeding in U.S. outpatient visits.
Jacob E. Kurlander,John N. Mafi,Michael J. Racz,Geoffrey D. Barnes,Sameer D. Saini,Patrick D. Meek,Elliot B Tapper,Jeffrey T. Kullgren,Joel H. Rubenstein,Caroline R. Richardson,Danielle Helminski +10 more
TL;DR: This study examines contemporary use and prescribing of proton pump inhibitors (PPIs) for gastrointestinal prophylaxis in US outpatient visits, particularly in high-risk patients for upper gastrointestinal bleeding, and compares it to acid-related disorder diagnoses.
1